Hiraki Akio, Matsuo Keitaro, Wakai Kenji, Suzuki Takeshi, Hasegawa Yasuhisa, Tajima Kazuo
Division of Epidemiology and Prevention, Aichi Cancer Center, Nagoya, Japan.
Cancer Sci. 2007 Jul;98(7):1087-91. doi: 10.1111/j.1349-7006.2007.00505.x. Epub 2007 May 8.
Alcohol consumption is a strong risk factor for squamous cell carcinoma of the head and neck (SCCHN). The genetic polymorphisms aldehyde dehydrogenase2 (ALDH2) Glu487Lys and alcohol dehydrogenase 2 (ADH2) His47Arg, which have a strong impact on alcohol metabolism, are common in the Japanese population. To clarify the significance of these polymorphisms in SCCHN carcinogenesis, we conducted a matched case-control study with 239 incident SCCHN subjects and 716 non-cancer controls. Both ADH2 Arg/Arg and ALDH2 Glu/Lys were found to be independently associated with increased risk, with odds ratios (OR) of 2.67 (95% confidence interval [CI] 1.51-4.57) and 1.66 (95% CI 1.20-2.31), respectively. Further, compared with subjects having both ADH2 His/His and ALDH2 Glu/Glu, the adjusted OR and its 95% CI for those with both ADH2 Arg/Arg and ALDH2 Glu/Lys was 5.00 (2.32-10.71) in all subjects. This combination effect was evident in heavy drinkers (OR 11.3, 95% CI 2.97-43.3) but not in moderate or non-drinkers. Statistically significant gene-environment interactions between the two polymorphisms and drinking level were seen (ADH2 P = 0.035, ALDH2, P = 0.013). Furthermore, we also found a statistically significant gene-gene interaction between the two polymorphisms (P = 0.042). In conclusion, this case-control study showed a significantly increased risk of SCCHN in subjects with the ADH2 Arg/Arg and ALDH2 Glu/Lys polymorphisms in a Japanese population. In addition, our results also demonstrated that this risk was associated with significant gene-gene interactions between ADH2 and ALDH2 polymorphisms, as well as gene-environment interactions between these polymorphisms and alcohol drinking.
饮酒是头颈部鳞状细胞癌(SCCHN)的一个重要风险因素。对酒精代谢有强烈影响的基因多态性醛脱氢酶2(ALDH2)Glu487Lys和酒精脱氢酶2(ADH2)His47Arg在日本人群中很常见。为了阐明这些多态性在SCCHN致癌过程中的意义,我们对239例初发SCCHN患者和716例非癌症对照进行了一项匹配病例对照研究。发现ADH2 Arg/Arg和ALDH2 Glu/Lys均与风险增加独立相关,优势比(OR)分别为2.67(95%置信区间[CI] 1.51 - 4.57)和1.66(95% CI 1.20 - 2.31)。此外,与同时具有ADH2 His/His和ALDH2 Glu/Glu的受试者相比,在所有受试者中,同时具有ADH2 Arg/Arg和ALDH2 Glu/Lys者的调整后OR及其95% CI为5.00(2.32 - 10.71)。这种联合效应在重度饮酒者中明显(OR 11.3,95% CI 2.97 - 43.3),但在中度或非饮酒者中不明显。观察到这两种多态性与饮酒水平之间存在统计学上显著的基因 - 环境相互作用(ADH2 P = 0.035,ALDH2,P = 0.013)。此外,我们还发现这两种多态性之间存在统计学上显著的基因 - 基因相互作用(P = 0.042)。总之,这项病例对照研究表明,在日本人群中,具有ADH2 Arg/Arg和ALDH2 Glu/Lys多态性的受试者患SCCHN的风险显著增加。此外,我们的结果还表明,这种风险与ADH2和ALDH2多态性之间显著的基因 - 基因相互作用以及这些多态性与饮酒之间的基因 - 环境相互作用有关。